Search Results 991-1000 of 21425 for anti-TNF drugs

  1. Science Saturday: Finding the right drug, dose for cancer therapy through pharmacogenomics - Mayo Clinic News Network

    Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...

  2. Natalizumab-Sztn (Intravenous Route) Description and Brand Names - Mayo Clinic

    Natalizumab-sztn injection is also used to treat moderate to severe Crohn's disease (CD) when other medicines or treatments did not work well.

  3. Bimekizumab-Bkzx (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Teriparatide (Subcutaneous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Mayo Clinic researchers identify cancer-fighting drugs that help morbidly obese mice to lose weight

    “We were surprised to observe that when morbidly obese mice were treated with certain cancer-fighting drugs, the drugs not only targeted their cancers, but ...

  6. Sulfadiazine (Oral Route) Before Using - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  7. Fluorouracil (Topical Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. It is very important that you use this medicine only as directed by your doctor.

  8. Pulmonary Medicine News - Medical Professionals - Mayo Clinic

    Updates in interstitial lung disease: Current facets of anti-fibrotic therapy. Teng Moua, M.D., discusses recent clinical trials and current research into the ...

  9. A Trial of Tumor Necrosis Factor Alpha and Interleukin-2 Coding Oncolytic Adenovirus (TILT-123) Combined with Pembrolizumab to Treat Refractory Ovarian Cancer - Mayo Clinic

    - Treated with any anti-cancer therapy within 30 days prior to the first virus injection. Anti-cancer therapy is defined as anti-cancer agents (e.g. surgery,

  10. Tirzepatide (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...